Rijksinstituut voor Volksgezondheid en Milieu
The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant | RIVM
Bron:
rivm.nl